106 related articles for article (PubMed ID: 38767046)
1. Performance of T2 mapping in the staging of Graves' ophthalmopathy based on different region of interest selection methods.
Yang L; Dai X; Su J; Yang S; Zheng Y; Ma M; Yu S
Acta Radiol; 2024 May; ():2841851241248640. PubMed ID: 38767046
[TBL] [Abstract][Full Text] [Related]
2. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.
Chen W; Hu H; Chen HH; Su GY; Yang T; Xu XQ; Wu FY
Acta Radiol; 2020 Nov; 61(11):1512-1519. PubMed ID: 32053002
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z
Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707
[TBL] [Abstract][Full Text] [Related]
4. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
5. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
6. The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves' ophthalmopathy compared to clinical activity scores.
Jiang M; Song X; Zhang H; Tao X; Yang G; Wang Y; Liu Y; Zhou H; Sun J; Li Y
Endocrine; 2022 Nov; 78(2):321-328. PubMed ID: 35997966
[TBL] [Abstract][Full Text] [Related]
7. Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves' Ophthalmopathy.
Liu X; Su Y; Jiang M; Fang S; Huang Y; Li Y; Zhong S; Wang Y; Zhang S; Wu Y; Sun J; Fan X; Zhou H
Endocr Pract; 2021 Mar; 27(3):198-205. PubMed ID: 33658136
[TBL] [Abstract][Full Text] [Related]
8. Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves' ophthalmopathy.
Wu D; Zhu H; Hong S; Li B; Zou M; Ma X; Zhao X; Wan P; Yang Z; Li Y; Xiao H
Eur J Radiol; 2021 Aug; 141():109815. PubMed ID: 34130234
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of activity of Graves' orbitopathy with multiparameter orbital magnetic resonance imaging (MRI).
Cheng J; Zhang X; Lian J; Piao Z; Zhou L; Gou X; Chen C; Chen L; Jiang K; Cheng J; Ji L; Hong N
Quant Imaging Med Surg; 2023 May; 13(5):3040-3049. PubMed ID: 37179934
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ
Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397
[TBL] [Abstract][Full Text] [Related]
14. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
[TBL] [Abstract][Full Text] [Related]
15. Low signal intensities of MRI T1 mapping predict refractory diplopia in Graves' ophthalmopathy.
Matsuzawa K; Izawa S; Kato A; Fukaya K; Matsumoto K; Okura T; Miyazaki D; Kurosaki M; Fujii S; Taniguchi SI; Kato M; Yamamoto K
Clin Endocrinol (Oxf); 2020 Jun; 92(6):536-544. PubMed ID: 32090348
[TBL] [Abstract][Full Text] [Related]
16. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
[TBL] [Abstract][Full Text] [Related]
17. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods.
Li D; Guo X; Zeng J; Feng H; Zhu T; Li H
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38639286
[TBL] [Abstract][Full Text] [Related]
18. Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI.
Chen L; Chen W; Chen HH; Wu Q; Xu XQ; Hu H; Wu FY
Int J Endocrinol; 2020; 2020():2575710. PubMed ID: 33144856
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging.
Hu H; Xu XQ; Wu FY; Chen HH; Su GY; Shen J; Hong XN; Shi HB
Exp Ther Med; 2016 Aug; 12(2):725-729. PubMed ID: 27446267
[TBL] [Abstract][Full Text] [Related]
20. Deep learning-based diagnosis of disease activity in patients with Graves' orbitopathy using orbital SPECT/CT.
Yao N; Li L; Gao Z; Zhao C; Li Y; Han C; Nan J; Zhu Z; Xiao Y; Zhu F; Zhao M; Zhou W
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3666-3674. PubMed ID: 37395800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
